Prognostic relevance of visit-to-visit office blood pressure variability in Systolic Blood Pressure Intervention Trial: Same data, different conclusions?

Tara I. Chang, David M. Reboussin, Glenn M. Chertow, Alfred K. Cheung, William C. Cushman, William J. Kostis, Gianfranco Parati, Erik Riessen, Brian P Shapiro, George S. Stergiou, Konstantinos Tsioufis, Paul K. Whelton, Jeffrey Whittle, Jackson T. Wright, Vasilios Papademetriou

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)1644-1645
Number of pages2
JournalJournal of Clinical Hypertension
Volume20
Issue number11
DOIs
StatePublished - Nov 1 2018
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

Chang, T. I., Reboussin, D. M., Chertow, G. M., Cheung, A. K., Cushman, W. C., Kostis, W. J., Parati, G., Riessen, E., Shapiro, B. P., Stergiou, G. S., Tsioufis, K., Whelton, P. K., Whittle, J., Wright, J. T., & Papademetriou, V. (2018). Prognostic relevance of visit-to-visit office blood pressure variability in Systolic Blood Pressure Intervention Trial: Same data, different conclusions? Journal of Clinical Hypertension, 20(11), 1644-1645. https://doi.org/10.1111/jch.13395